Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
20,564 total articles
Figure Technology Solutions finalized its acquisition of Kiavi, the leading Residential Transition Loan lender, to enhance its blockchain-based capital marketplace. The integration is expected to broaden access to Kiavi's lending technologies within Figure's extensive ecosystem, accelerating growth in the $35 trillion home equity market. The deal i…
TransUnion's marketing campaign for its TruAudience Marketing Solutions, titled 'Bring Clarity to Chaos,' was named a finalist for the 2026 AdExchanger Awards in the Most Innovative Marketing Campaign category. The campaign's omnichannel strategy effectively connected fragmented marketing ecosystems, engaging B2B buyers across multiple platforms. T…
Septerna, Inc., a clinical-stage biotech focusing on GPCR drug discovery, announced management's participation in two major healthcare investor conferences in September 2026, including live webcasts. The company highlights its proprietary technology platform and diverse pipeline targeting endocrinology, immunology, inflammation, and metabolic disea…
BlackLine, Inc. announced it has achieved PCI DSS compliance validation for its PCI Detokenization Service. This enables organizations to securely automate complex workflows involving sensitive payment card data by combining secure access with BlackLine's high-volume transaction matching and reconciliation technology. The validation allows the comp…
Relmada Therapeutics, a clinical-stage biotech company focusing on oncology and CNS disorders, announced participation in the Wells Fargo Healthcare Conference with senior management conducting one-on-one meetings to discuss their clinical programs and corporate progress.
CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, announced its management's participation in several prestigious healthcare investor conferences in September 2026, including Wells Fargo, Cantor Global, and Morgan Stanley events. The company focuses on developing novel conditionally activated PROBODY therapeutics des…
FTC Solar announced that Enertis Applus+ has independently validated the performance of its SUNPATH® software. The study showed that the optimization software provides consistent and predictable energy gains across utility-scale solar projects in the U.S., with measured energy production increases closely matching modeled estimates. This validation…
Aduro Clean Technologies Inc. reported its fourth quarter and fiscal 2026 results highlighting substantial investments in pilot plant operations, engineering, and project development. The company transitioned its Next Generation Process Pilot Plant into structured operations and progressed its First-of-a-Kind program. Aduro strengthened its financi…
Metagenomi Therapeutics, an in vivo genome editing company, announced that its President and CEO will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference. The company focuses on developing proprietary CRISPR-based genetic medicines, with a lead program targeting hemophilia A showing promising preclinical results.
BIO-key International, a leader in biometric identity and access management solutions, announced that CEO Michael DePasquale will participate in virtual meetings and present at the H.C. Wainwright Global Investment Conference in September 2026. The company's presentation will be available on demand to registered attendees, highlighting its biometri…
Emergent BioSolutions has been awarded a $24 million contract modification by BARDA, part of the U.S. Department of Health and Human Services, to supply its CYFENDUS® anthrax vaccine. This contract supports the U.S. government's ongoing anthrax preparedness efforts amid biological threats. CYFENDUS®, FDA-approved in 2023 for post-exposure prophylax…
Kayne Anderson Energy Infrastructure Fund, Inc. declared a monthly distribution of $0.09 per common share payable on September 30, 2026. The fund focuses on energy infrastructure securities and aims to provide high after-tax returns with an emphasis on cash distributions. Distribution amounts may vary and are subject to Board approval and financial…
Sezzle Inc. announced that Gymshark, Debenhams Group (including its multiple brands), and Follett Higher Education are now offering Sezzle as a payment option at checkout. This expansion comes during a record back-to-school shopping season, providing flexible payment solutions for budget-conscious students and families. With Sezzle's point-of-sale …
3 E Network Technology Group Limited announced that its wholly owned subsidiary secured a $1.2 million sales order for enterprise-grade DDR4 memory chips. This order demonstrates the company's capabilities in hardware supply amid growing IT infrastructure upgrades and provides additional revenue to support its AI infrastructure R&D efforts. The ord…
NorthStrive Biosciences, a subsidiary of PMGC Holdings (NASDAQ: ELAB), announced an expanded three-phase program with Yuva Biosciences to advance four AI-discovered compounds toward lead nomination for developing potential therapies in cardiac diseases and obesity. The program builds upon positive Phase III results and aims to de-risk and narrow ca…
Kala Bio and Virotek announced a letter of intent to establish an exclusive U.S. distribution partnership where Kala will market and distribute Virotek's genetic testing program for ophthalmology. This collaboration aligns with Kala's strategic focus on eye care and provides a near-term commercial revenue opportunity while extending Kala's reach in…
Heidmar Maritime Holdings Corp. reported robust second quarter and first half 2026 results with total revenues of $29.0 million in Q2, a significant increase from $9.6 million in Q2 2025, driven by growth in commercially managed vessels and higher chartering activity. Net income attributable to shareholders rose to $2.2 million in Q2 2026 compared …
Clearmind Medicine Inc. has initiated Phase IIa of its Phase I/IIa clinical trial evaluating CMND-100, a non-hallucinogenic psychedelic-derived therapeutic candidate, for the treatment of Alcohol Use Disorder (AUD). Six patients have been enrolled so far across medical centers in Israel, marking progression into the multiple-dose treatment phase fo…
Vera Therapeutics, a US-based commercial-stage biotech company specializing in autoimmune kidney diseases, will present at the Cantor Global Healthcare Conference and the Morgan Stanley Global Healthcare Conference in September 2026. The company's management aims to engage investors through fireside chats and one-on-one meetings, highlighting their…
Alumis announced that its Phase 2b LUMUS trial of envudeucitinib in moderate-to-severe systemic lupus erythematosus (SLE) did not meet primary and secondary endpoints in the overall population. However, robust responses in the prespecified interferon gene signature-high (IFNGS-high) subgroup, representing most moderate-to-severe SLE cases, support …
KANZHUN LIMITED, a leading Chinese online recruitment platform, announced the rotation of its president position effective September 1, 2026. Mr. Xu Chen steps down as president but remains as executive director and Chief Marketing Officer, while Mr. Tao Zhang takes over as rotating president alongside his roles as executive director and Chief Tech…
BridgeBio Pharma, a biopharmaceutical company focused on genetic condition medicines, announced that its management will participate in several upcoming healthcare investor conferences in September 2026. These include Wells Fargo, Cantor Global, Morgan Stanley, and Bernstein Insights conferences. The company aims to communicate its developments and…
Ardelyx Inc., a US commercial-stage biopharmaceutical company, has announced its participation in several major investor conferences in New York during September 2026, including Citi, Cantor, and Morgan Stanley healthcare events. The company will host fireside chats and investor meetings, providing updates on its commercial products IBSRELA and XPH…
Streamex Corp., a Nasdaq-listed technology company specializing in tokenization of commodity assets, appointed Laura Kiernan as Head of Investor Relations. Kiernan brings over 30 years of capital markets experience to lead investor relations strategy, aiming to bridge the value of Streamex's platform with market perception. The move supports Stream…
FocalTherics, a leader in robotic focal therapy, announced that its CEO and CFO will present and host investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference in New York on September 15-16, 2026. The company focuses on minimally invasive medical devices leveraging proprietary focused ultrasound technology to treat various …
